September 30, 2016 1:40 AM ET

Capital Markets

Company Overview of Lilly Asia Ventures

Company Overview

Lilly Asian Ventures is a venture capital arm of Eli Lilly & Co. It specializes in investments in growth stage and various stages of development from start-up to commercialization. It primarily invests in life science and healthcare sectors. It typically invests in human therapeutics with a focus on pharmaceuticals, biotechnology, biomedicine, and medical treatment equipment; medical technology with a focus on devices and diagnostics; healthcare services with a focus on hospitals, clinics, etc; animal health; and broader life sciences including industrial biotechnology, agricultural biotechnology, and nutraceuticals. It prefers to invest in companies based in Asia with a focus on China. It s...

Room 2909, 3 Corporate Avenue

No. 168 Hubin Road

Huangpu

Shanghai,  200021

China

Founded in 2007

Phone:

86 21 2316 9588

Fax:

86 21 6340 6183

Key Executives for Lilly Asia Ventures

Founder, Managing Director, and Managing partner
Senior Managing Director
Operation Manager and Senior Manager
Investment Director and Managing partner
Partner
Compensation as of Fiscal Year 2016.

Lilly Asia Ventures Key Developments

Lilly Asia Ventures Presents at 11th Annual SuperReturn Asia 2016, Sep-26-2016 03:55 PM

Lilly Asia Ventures Presents at 11th Annual SuperReturn Asia 2016, Sep-26-2016 03:55 PM. Venue: JW Marriott Hong, Hong Kong. Speakers: Judith Li, Partner.

Lilly Asia Ventures Presents at Redefining Early Stage Investments (RESI) Conference, Sep-13-2016 04:00 PM

Lilly Asia Ventures Presents at Redefining Early Stage Investments (RESI) Conference, Sep-13-2016 04:00 PM. Venue: The Westin Copley Place, 10 Huntington Ave, Boston, MA 02116, United States. Speakers: Wei Zhang, Entrepreneur in Residence.

Lilly Asia Ventures Presents at HKVCA 15th China Private Equity Summit, May-30-2016

Lilly Asia Ventures Presents at HKVCA 15th China Private Equity Summit, May-30-2016 . Venue: N201, Hong Kong Convention and Exhibition Centre (New Wing), Hong Kong. Speakers: Yi Shi, Founder, Managing Director, and Managing partner.

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 27, 2016
Fortis Therapeutics, Inc.
Private Placement
September 16, 2016
READCOOR, INC.
Private Placement
August 22, 2016
Singlera Genomics Inc.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Lilly Asia Ventures, please visit www.lillyasiaventures.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.